Financial reports
10-K
2023 FY
Annual report
6 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Unregistered Sales of Equity Securities
23 Apr 24
8-K
Unregistered Sales of Equity Securities
23 Jan 24
8-K
Departure of Directors or Certain Officers
20 Dec 23
8-K
Regulation FD Disclosure
12 Dec 23
8-K
Unregistered Sales of Equity Securities
23 Oct 23
8-K
Entry into a Material Definitive Agreement
24 Jul 23
8-K
Unregistered Sales of Equity Securities
25 Apr 23
8-K
Regulation FD Disclosure
2 Mar 23
8-K
Unregistered Sales of Equity Securities
24 Jan 23
8-K
Regulation FD Disclosure
16 Nov 22
Registration and prospectus
SC TO-I/A
Issuer tender offer statement (amended)
23 Apr 24
SC TO-I
Issuer tender offer statement
15 Apr 24
D/A
Indefinite amount in equity, sold $349.40 mm, 8 investors
28 Mar 24
SC TO-I/A
Issuer tender offer statement (amended)
13 Feb 24
SC TO-I/A
Issuer tender offer statement (amended)
23 Jan 24
SC TO-I/A
Issuer tender offer statement (amended)
16 Jan 24
SC TO-I
Issuer tender offer statement
12 Jan 24
SC TO-I/A
Issuer tender offer statement (amended)
13 Nov 23
SC TO-I/A
Issuer tender offer statement (amended)
23 Oct 23
SC TO-I
Issuer tender offer statement
13 Oct 23
Proxies
No filings
Other
No filings